Edgar Snyder & Associates®
A Law Firm Representing Injured People
1-866-943-3427
Call Us Toll Free 24/7
Published on Nov 17, 2006 by Edgar Snyder

FDA Panel to Review Safety of Drugs in Children

child

The Food and Drug Administration’s (FDA) pediatric advisory committee met to review safety reports on various drugs. The panel is reviewing 16 drugs to determine if they should be used in pediatric patients.

The eight drugs that raise questions about safety include:

  • Pfizer’s Zyvox
  • GlaxoSmithKline PLC’s Zofran and Avandia
  • Forest Laboratories Inc.’s Celexa
  • Novartis AG’s Trileptal
  • Wyeth’s Rapamune
  • Abbott Laboratories’ Norvir

Eight other drugs under review are not expected to raise any concerns. The panel will make recommendations that could include label changes or further studies into the adverse events the drugs may cause in children.

Please note: All of our lawyers are licensed to practice in the state of Pennsylvania. We also have lawyers licensed to practice in Ohio, and West Virginia and we associate with experienced attorneys in other states. In addition, all drug-related litigation involves co-counsel.

Source: “FDA Panel Set to Issue Opinions On Safety of 16 Drugs in Children.” By Patricia Kowsmann. The Wall Street Journal. November 16, 2006.
Think you have a case?
Think you have a case?
Free Case Review
First Name
Last Name
ZIP
Phone
Email
Briefly describe your injuries

Recent News

Sep 28, 2016
Pittsburgh Police Beefing Up DUI Patrols in 2017
Sep 26, 2016
Gear Up, Cool Down, and Stay Safe While Riding This Fall
Sep 16, 2016
Fall and Winter Car Kit
Sep 16, 2016
A New Law May Be Coming for Drivers
Sep 16, 2016
Smartphone Apps for Drivers
Tweet